Jan 18, 2019 02:58 PM IST
Net Sales are expected to increase by 32.4 percent Y-o-Y (up 6 percent Q-o-Q) to Rs. 1,400.7 crore, according to Sharekhan.
- Jan 11, 2019 05:26 PM IST
Net Sales are expected to increase by 30.7 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs. 1,382.4 crore, according to ICICI Direct.
- Dec 19, 2018 11:46 AM IST
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.
- Dec 17, 2018 11:44 AM IST
The inspection was concluded without any observations and no Form 483 was issued, the company added.
- Nov 30, 2018 06:22 PM IST
Fulphila, a biosimilar Pegfilgrastim, jointly developed by Biocon and Mylan, has been approved in European Union (EU), Biocon said in a regulatory filing.
- Nov 29, 2018 04:45 PM IST
"The erstwhile UPA regime and the present Modi government have taken some good steps, but have not done enough to improve the economy," Shaw told PTI in an interview after the inauguration of Bengaluru Tech Summit 2018.
- Nov 28, 2018 10:34 AM IST
A sustained move above the 200-SMA i.e. 10,753 will extend the uptrend taking the Index to levels of 10,850-10,980. However, failure to cross this resistance on the way up can trigger profit booking.
- Nov 09, 2018 09:41 AM IST
Citi added that Biocon is one of its top picks. Risk-reward ratio is favourable at current levels
- Nov 08, 2018 11:16 AM IST
Indian markets will be impacted by many impending global factors in the next 1 year. As global trade tiffs are increasingly turning into standoffs, trade and capital flows to and from India would definitely be affected.
- Oct 26, 2018 09:36 PM IST
“Overall, we have a nice basket of biosimilars for both the US and European market, which will set us up for a steady growth in that segment going forward,” said Shaw.
- Oct 26, 2018 02:46 PM IST
Brokerage house sees an upside of 19-34 percent in these stocks; names such as MindTree, RIL figure in the list.
- Oct 26, 2018 12:32 PM IST
- Oct 26, 2018 12:31 PM IST
- Oct 25, 2018 08:53 PM IST
The growth was led by the launch of biosimilar pegfilgrastim by Biocon's partner Mylan in US and strong performance across small molecules and research services segments.
- Oct 23, 2018 10:31 AM IST
Experts feel that investors sitting on cash should buy into markets in a scattered manner instead of making a lump sum payment.
- Oct 20, 2018 12:55 PM IST
Trastuzumab, the biosimilar version of Swiss drug maker Roche’s Herceptin had brand sales of $1.9 billion in Europe for the 12 months ended July 31, according to IQVIA.
- Oct 19, 2018 02:02 PM IST
According to the latest report by IMF, India is poised to grow at 7.4 percent in 2018 and 7.8 percent in 2019, making it the fastest growing economy among peers overtaking China.
- Oct 16, 2018 07:22 PM IST
Net Sales are expected to increase by 19.1 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 1,154 crore, according to Sharekhan.
- Oct 12, 2018 04:07 PM IST
Net Sales are expected to increase by 28.6 percent Y-o-Y (up 10.8 percent Q-o-Q) to Rs. 1,245.4 crore, according to ICICI Direct.
- Sep 21, 2018 07:56 PM IST
Amgen's Neulasta had brand sales of more than $450 million in Europe for the 12 months ending June 30, 2018, according to market research firm IQVIA.
- Jul 26, 2018 07:55 PM IST
Total revenue for the quarter under review grew 21 percent to Rs 1,192 crore in the April-June period.
- Jul 26, 2018 10:22 AM IST
The company's performance in the June quarter is also expected to augmented by the performance of its biologics, branded formulations and research services segments
- Jul 18, 2018 02:08 PM IST
Net Sales are expected to increase by 24.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 1,162 crore, according to Kotak.
- Jul 14, 2018 01:50 PM IST
When a set of factors that have panned out in the past tends to repeat itself in the future, we expect the same outcome to occur, as was observed in the past.
- Jul 05, 2018 10:21 AM IST
Bangalore facility is used for the manufacture of portfolio of biosimilars.